tiprankstipranks
Valerio Therapeutics (FR:ALVIO)
:ALVIO
France Market
ALVIO
Valerio Therapeutics
RESEARCH TOOLSreports
Want to see FR:ALVIO full AI Analyst Report?

Valerio Therapeutics (ALVIO) Income Statement

0 Followers

Valerio Therapeutics Income Statement

Last quarter (Q4 2025), Valerio Therapeutics's total revenue was €2.45M, an increase of 35.94% from the same quarter last year. In Q4, Valerio Therapeutics's net income was €-4.69M. See Valerio Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Jun 25Dec 23Dec 22Dec 21
Total Revenue
€ 2.57M€ 1.79M€ 1.80M€ 1.44M€ 4.06M
Gross Profit
€ 1.73M€ 1.28M€ 1.27M€ 929.00K€ 3.69M
Operating Expenses
€ 2.28M€ 17.77M€ 21.55M€ 17.66M€ 8.84M
Depreciation and Amortization
€ 4.90M€ 11.31M€ 1.74M€ 33.00K€ 511.00K
EBITDA
€ 542.00K€ -12.06M€ -18.44M€ -17.04M€ -5.86M
Operating Income
€ -550.00K€ -16.49M€ -20.29M€ -17.11M€ -7.33M
Other Income/Expenses
€ -4.09M€ -7.06M€ -39.00K€ -2.16M€ -255.00K
Pretax Income
€ -4.64M€ -23.55M€ -20.33M€ -19.27M€ -7.58M
Net Income
€ -4.90M€ -23.93M€ -20.34M€ -19.56M€ -5.94M
Per Share Metrics
Basic EPS
€ -0.03€ -0.16€ -0.15€ -0.18€ -0.07
Diluted EPS
€ -0.03€ -0.16€ -0.15€ -0.18€ -0.07
Weighted Average Shares Outstanding
 154.36M 153.88M 135.63M 105.75M 88.21M
Weighted Average Shares Outstanding (Diluted)
 154.36M 153.88M 135.63M 105.75M 88.21M
Currency in EUR

Valerio Therapeutics Earnings and Revenue History